The accelerated approval for Jazz Pharmaceuticals’ small cell lung cancer (SCLC) drug Zepzelca may once again be in jeopardy.

An independent research firm is reviewing data on Amgen’s Tavneos as the company prepares for a hearing later this month with ...

Audio is becoming an increasingly important area of focus in pharma marketing, and now four big drugmakers have become ...

Staring down a $6 billion patent cliff for its prostate cancer drug Xtandi, Astellas aims to counter the inevitable revenue ...

Astellas CEO explained to Fierce the company's new five-year plan. A Takeda candidate beat Bristol Myers Squibb's Sotyktu in a head-to-head psoriasis trial. | Astellas CEO explained to Fierce the ...

While patients in Novo trials don't need to take any action, the company recommends patients "remain vigilant and report to ...

With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries are calling for ...

Last year, Johnson & Johnson arrived late to the party with Imaavy as the third FcRn blocker approved since 2021 to treat ...

Madrigal Pharmaceuticals has installed a 20-foot-tall, 41-foot-wide inflatable liver in a Philadelphia park to mark Global ...

Teva Pharmaceuticals plans to remove 250 jobs at its CDMO unit over the next two years, Israeli business news outlet Globes ...

Three short films created through an Eli Lilly-sponsored initiative are premiering at the Tribeca Festival, furthering the ...

Almost two-thirds of Americans who have asked artificial intelligence tools for medical advice acted on the guidance without ...